Background Although a number of antiviral agents have been evaluated for coronaviruses
there are no approved drugs available. To provide an overview of the landscape of …

Background To better inform clinical practice, we summarized the findings from randomized
controlled trials (RCTs) of antivirals for COVID-19. Methods We systematically searched for …

Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Abstract Background Coronavirus disease 2019 (COVID-19) is a major public health
concern currently. To date, there are no approved antiviral drugs or vaccines against this …

Background: The COVID-19 pandemic is characterized by an unprecedented urgency to
obtain reliable information on therapeutic options and their evaluation in clinical trials …

BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …

ABSTRACT Introduction Coronavirus Disease 2019 is a contagious infection that has
infected millions worldwide. The objective of this systematic review is to identify studies …

Background: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but safe
and effective treatment options remain unavailable. Numerous systematic reviews of varying …

Objectives Due to the rapid spread of COVID-19 worldwide, many countries have designed
clinical trials to find efficient treatments. We aimed to critically report the characteristics of all …

Background Since the outbreak of coronavirus disease 2019 (COVID-19), many researchers
in China have performed related clinical research. However, systematic reviews of the …